EUTM file information

018565093

NORGINE


September 23, 2021

Trademark Summary

The trademark application NORGINE was filed by Velinor AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on October 18, 2021, and it was registered by office on January 25, 2022 without any oppositions.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations
    2. Dietetic substances and foods for medical use
    3. Dietetic supplements for human beings
    4. Plasters, materials for dressings.
  • The mark was filed in class 10 with Medical and surgical apparatus and instruments and diagnostic apparatus for medical use..
  • The mark was filed in class 36 with following description of goods:
    1. Financial services
    2. Credit and lending services
    3. Arranging financing for commercial companies
    4. Provision of financing to health care companies
    5. Venture capital financing
    6. Fundraising services
    7. Financial sponsorship of activities and events.
  • The mark was filed in class 41 with following description of goods:
    1. Educational services provided in the medical field
    2. Medical training and teaching
    3. Teaching services relating to pharmaceutical products and medical conditions
    4. Arranging and conducting of courses, seminars, workshops, conferences, symposiums in the field of medicine and medical science
    5. Editing of medical publications
    6. Teaching services in the field of medicine.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and technological services as well as research and design relating thereto
    2. Research and development services in the pharmaceutical field
    3. Conducting clinical trials
    4. Provision of information relating to medical and scientific research in the field of pharmaceutical products and clinical trials.
Trademarkers